ArticleHuman mutation2026
Visualization and Cluster Analysis of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer: Research Trends and Future Directions.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Peroxisome proliferator-activated receptors (PPARs) are essential regulators in the development and progression of colorectal cancer (CRC). However, a comprehensive bibliometric analysis of PPAR-related CRC research is lacking. Methods: Publications on PPARs in CRC from 1998 to 2024 were retrieved from the Web of Science Core Collection. VOSviewer, CiteSpace, and the R package bibliometrix were used to analyze publication trends, hotspots, and collaboration networks. Contributions from countries, institutions, authors, and journals were systematically evaluated. Results: A total of 1380 publications were analyzed, with an annual growth rate of 8.33%. The United States led with the highest number of publications (386) and citations (28,461), followed by China and Japan. The University of Texas System was the most productive institution (125 publications). Gonzalez, Frank J. and Peters, Jeffrey M. were the most prolific authors (16 publications each). Conclusion: This study highlights three key research focuses: molecular mechanisms of PPARs in CRC, the link between obesity and CRC, and therapeutic potential. These findings underscore the growing interest in PPAR-mediated metabolic regulation, inflammation, and targeted interventions, offering valuable guidance for future research directions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.